NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 57 min 55 sec ago

NIBIB Supplements to NCATS CTSA Programs to Support NIBIB Translational Research Scholars (Admin Supp Clinical Trials Optional)

Thu, 2018-07-05 11:40
Funding Opportunity PA-18-851 from the NIH Guide for Grants and Contracts. The purpose of this administrative supplement is to facilitate translational research partnerships between junior researchers with quantitative backgrounds (in engineering or computational or physical sciences) and junior clinician-scientists from active CTSA institutions (PAR-15-304, PAR-18-464). The supplement will support the quantitative researcher, the NIBIB Translational Research Scholar, contingent upon his/her collaborating with a clinician-scientist KL2 scholar, the "partnering clinician-scientist". The partnering clinician-scientist will be supported independently of this supplement through the parent KL2 award throughout the duration of the proposed supplement. Both team members will be selected by the KL2 PI. The KL2 PI will assist the NIBIB Translational Research Scholar and the partnering clinician-scientist in developing a translational research project aligned with NIBIBs research mission under the guidance of their identified basic and clinical/translational science mentors. Based on this project, the KL2 PI will submit a supplement request under this FOA.

Administrative Supplements to Promote Collaborative Activities in Basic Cancer Research (Admin Supp - Clinical Trial Not Allowed)

Thu, 2018-07-05 11:15
Funding Opportunity PA-18-852 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to incentivize collaborative, multidisciplinary research across a broad area of challenging topics in basic cancer biology. These supplement applications must propose a collaboration between at least two researchers, one being the PI of the parent NCI grant. Awarded supplements will leverage and extend currently funded cancer research in the parent grant.

Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional)

Thu, 2018-07-05 10:59
Funding Opportunity PA-18-849 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and wellness as individuals age and prevent illness and disability in later years.

Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional)

Thu, 2018-07-05 10:59
Funding Opportunity PA-18-850 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and wellness as individuals age and prevent illness and disability in later years.

Novel Approaches for Characterizing Exposure and Response to Engineered Nanomaterials (R43 Clinical Trials Not Allowed)

Tue, 2018-07-03 13:21
Funding Opportunity RFA-ES-18-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Phase I (R43) Small Business Innovative Research (SBIR) grant applications from small business concerns (SBCs) to develop and/or adapt novel technologies to enable the characterization of human exposures to engineered nanomaterials (ENMs) and to monitor or assess ENMs in diverse media ranging from biological samples to air and water.

Notice of Pre-application Webinar for RFA-CA-18-025 Cooperative Human Tissue Network (CHTN)

Tue, 2018-07-03 13:06
Notice NOT-CA-18-089 from the NIH Guide for Grants and Contracts

Updates for PAR-16-098 "Cooperative Research Agreements Related to World Trade Center Health Program (U01)"

Tue, 2018-07-03 12:24
Notice NOT-OH-18-009 from the NIH Guide for Grants and Contracts

NIDCD Hearing Healthcare for Adults: Improving Access and Affordability (R21/R33 Clinical Trials Optional)

Tue, 2018-07-03 12:18
Funding Opportunity RFA-DC-19-001 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages Exploratory/Developmental Phased Innovation (R21/R33) grant applications to support research and/or infrastructure needs in emerging scientific areas leading to more accessible and affordable hearing health care for adults with mild to moderate hearing loss. The proposed research aims should be milestone-driven and lead to better hearing healthcare, targeting enhanced access and affordability, in an effort to improve outcomes for adults with hearing loss. The total project period for an application submitted in response to this FOA may not exceed five years. This FOA provides support for up to two years (R21 phase) for preliminary/developmental studies, followed by possible transition of up to four years of expanded research and development support (R33). This FOA requires measurable R21 milestones.

Halting TB Transmission in HIV-Endemic and Other High-Transmission Settings (R01 Clinical Trial Not Allowed)

Tue, 2018-07-03 12:09
Funding Opportunity RFA-AI-18-037 from the NIH Guide for Grants and Contracts. The objectives of this Funding Opportunity Announcement are to promote research to: 1) understand the critical drivers of TB transmission at the individual and population levels in high-burden settings, particularly where high incidence of HIV co-infection contributes to TB rates. (This may include the aerobiology of infectious particles and environmental- and population-based factors.) 2) develop potential interventions to prevent TB transmission in HIV-endemic and other high-transmission settings and to measure the rate of transmission underpinned by an increased understanding of the biomedical basis of transmission and related risk factors.

NIMH Career Enhancement Award to Advance Autism Services for Adults and Transition-Age Youth (K18 Clinical Trials Required)

Tue, 2018-07-03 11:11
Funding Opportunity RFA-MH-19-101 from the NIH Guide for Grants and Contracts. This NIMH Research Career Enhancement Award (K18) program invites applications from experienced investigators seeking to redirect or expand their research programs through the acquisition of new skills and knowledge in areas beyond and complementary to their current areas of expertise. The program will support research training and career development experiences and a small-scale research project that will provide experienced investigators with the scientific competencies required to conduct research relevant to services for adults and transition-age youth with Autism Spectrum Disorders. Eligible candidates are independent investigators at any faculty rank or level. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA (FOA #).

NIMH Career Enhancement Award to Advance Autism Services for Adults and Transition-Age Youth (K18 Clinical Trials Not Allowed)

Tue, 2018-07-03 11:11
Funding Opportunity RFA-MH-19-100 from the NIH Guide for Grants and Contracts. This NIMH Research Career Enhancement Award (K18) program invites applications from experienced investigators seeking to redirect or expand their research programs through the acquisition of new skills and knowledge in areas beyond and complementary to their current areas of expertise. The program will support research training and career development experiences and a small-scale research project that will provide experienced investigators with the scientific competencies required to conduct research relevant to services for adults and transition-age youth with Autism Spectrum Disorders. Eligible candidates are independent investigators at any faculty rank or level. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary study to an ongoing clinical trial as lead investigator, should apply to the companion FOA RFA-MH-19-101.

Notice of NIMHD Participation in PA-18-343: "Academic Research Enhancement Award (R15 Clinical Trial Required)"

Tue, 2018-07-03 02:23
Notice NOT-MD-18-009 from the NIH Guide for Grants and Contracts

Notice of Modification to a Page Limitation in PAR-18-266 "Centers of Biomedical Research Excellence (COBRE)(P20)"

Tue, 2018-07-03 02:13
Notice NOT-GM-18-037 from the NIH Guide for Grants and Contracts

Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)

Tue, 2018-07-03 02:09
Funding Opportunity RFA-ES-18-002 from the NIH Guide for Grants and Contracts. The National Institute of Environmental Health Sciences (NIEHS) is announcing the continuation of the Superfund Hazardous Substance Research and Training Program, referred to as Superfund Research Program (SRP) Centers. SRP Center grants will support problem-based, solution-oriented research Centers that consist of multiple, integrated projects representing both the biomedical and environmental science and engineering disciplines; as well as cores tasked with administrative (which includes research translation), data management and analysis, community engagement, training, and research support functions. The scope of the SRP Centers is taken directly from the Superfund Amendments and Reauthorization Act of 1986, and includes: (1) advanced techniques for the detection, assessment, and evaluation of the effect on human health of hazardous substances; (2) methods to assess the risks to human health presented by hazardous substances; (3) methods and technologies to detect hazardous substances in the environment; and (4) basic biological, chemical, and physical methods to reduce the amount and toxicity of hazardous substances.

The National Health and Aging Trends Study (U01 Clinical Trial Not Allowed)

Tue, 2018-07-03 02:07
Funding Opportunity RFA-AG-19-019 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications for the next 5-year cycle of the National Health and Aging Trends Study (NHATS), the leading nationally representative, longitudinal, data resource in the US for research on trends, dynamics, and disparities in late-life disability, and for studies of the social and economic consequences of late-life disability for individuals, families and society, including caregiving and end-of-life issues. NHATS has conducted seven annual rounds of data collection to date (an eighth round is in process) and is linked to the separately-funded National Study of Caregiving (NSOC). The goals of the next cycle are to 1) Continue the current structure and design elements of NHATS; 2) Permit studies of long-term trends in disability prevalence; 3) Enrich measurement of cognitive capacity; 4) Enhance measurement of physical activity and sedentary behavior; 5) Continue linkages with administrative records; and 6) Augment data dissemination and user support.

Pages